Immunoprophylaxis of viral hepatitis: A practical guide

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There are presently available immune globulin preparations of proven efficacy and safety in the prophylaxis of type A and B viral hepatitis. Active vaccines for prevention of type B hepatitis are now available and are safe and effective. None of these preparations has been associated with the development of HTLV-III/LAV/HIV infection. Preexposure prophylaxis for type B hepatitis is indicated for health care workers who have frequent contact with blood, and most endoscopists would be among this group of high-risk individuals. Prenatal screening of pregnant women for HBsAg provides an opportunity to intervene in the vicious cycle of perpetuating a population of hepatitis B carriers via perinatal transmission. Unfortunately until serological tags for the non-A non-B hepatitis viruses are identified, there will be no effective vaccination for this form of hepatitis. Patients who already have acute or chronic viral hepatitis must await the advent of safe and effective antiviral agents for treatment of these viral infections.

Original languageEnglish
Pages (from-to)287-291
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume82
Issue number4
StatePublished - Jan 1 1987

Fingerprint

Hepatitis B
Hepatitis
HIV Infections
Hepatitis Viruses
Hepatitis B Vaccines
Virus Diseases
Chronic Hepatitis
Hepatitis B Surface Antigens
Prenatal Diagnosis
Antiviral Agents
Immunoglobulins
Pregnant Women
Vaccination
Delivery of Health Care
Safety
Population
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Immunoprophylaxis of viral hepatitis : A practical guide. / Schiff, Eugene R.

In: American Journal of Gastroenterology, Vol. 82, No. 4, 01.01.1987, p. 287-291.

Research output: Contribution to journalArticle

@article{3c9a5e5517ba4d6694b91487258bc869,
title = "Immunoprophylaxis of viral hepatitis: A practical guide",
abstract = "There are presently available immune globulin preparations of proven efficacy and safety in the prophylaxis of type A and B viral hepatitis. Active vaccines for prevention of type B hepatitis are now available and are safe and effective. None of these preparations has been associated with the development of HTLV-III/LAV/HIV infection. Preexposure prophylaxis for type B hepatitis is indicated for health care workers who have frequent contact with blood, and most endoscopists would be among this group of high-risk individuals. Prenatal screening of pregnant women for HBsAg provides an opportunity to intervene in the vicious cycle of perpetuating a population of hepatitis B carriers via perinatal transmission. Unfortunately until serological tags for the non-A non-B hepatitis viruses are identified, there will be no effective vaccination for this form of hepatitis. Patients who already have acute or chronic viral hepatitis must await the advent of safe and effective antiviral agents for treatment of these viral infections.",
author = "Schiff, {Eugene R}",
year = "1987",
month = "1",
day = "1",
language = "English",
volume = "82",
pages = "287--291",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Immunoprophylaxis of viral hepatitis

T2 - A practical guide

AU - Schiff, Eugene R

PY - 1987/1/1

Y1 - 1987/1/1

N2 - There are presently available immune globulin preparations of proven efficacy and safety in the prophylaxis of type A and B viral hepatitis. Active vaccines for prevention of type B hepatitis are now available and are safe and effective. None of these preparations has been associated with the development of HTLV-III/LAV/HIV infection. Preexposure prophylaxis for type B hepatitis is indicated for health care workers who have frequent contact with blood, and most endoscopists would be among this group of high-risk individuals. Prenatal screening of pregnant women for HBsAg provides an opportunity to intervene in the vicious cycle of perpetuating a population of hepatitis B carriers via perinatal transmission. Unfortunately until serological tags for the non-A non-B hepatitis viruses are identified, there will be no effective vaccination for this form of hepatitis. Patients who already have acute or chronic viral hepatitis must await the advent of safe and effective antiviral agents for treatment of these viral infections.

AB - There are presently available immune globulin preparations of proven efficacy and safety in the prophylaxis of type A and B viral hepatitis. Active vaccines for prevention of type B hepatitis are now available and are safe and effective. None of these preparations has been associated with the development of HTLV-III/LAV/HIV infection. Preexposure prophylaxis for type B hepatitis is indicated for health care workers who have frequent contact with blood, and most endoscopists would be among this group of high-risk individuals. Prenatal screening of pregnant women for HBsAg provides an opportunity to intervene in the vicious cycle of perpetuating a population of hepatitis B carriers via perinatal transmission. Unfortunately until serological tags for the non-A non-B hepatitis viruses are identified, there will be no effective vaccination for this form of hepatitis. Patients who already have acute or chronic viral hepatitis must await the advent of safe and effective antiviral agents for treatment of these viral infections.

UR - http://www.scopus.com/inward/record.url?scp=0023182089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023182089&partnerID=8YFLogxK

M3 - Article

C2 - 3031979

AN - SCOPUS:0023182089

VL - 82

SP - 287

EP - 291

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -